Rockwell Medical, Inc.
Index- P/E- EPS (ttm)-0.35 Insider Own- Shs Outstand93.88M Perf Week-16.77%
Market Cap12.65M Forward P/E- EPS next Y-3.92 Insider Trans- Shs Float7.71M Perf Month-61.46%
Income-32.40M PEG- EPS next Q-0.84 Inst Own92.80% Short Float2.31% Perf Quarter-62.50%
Sales61.80M P/S0.20 EPS this Y27.10% Inst Trans2.75% Short Ratio3.35 Perf Half Y-71.06%
Book/sh0.12 P/B11.58 EPS next Y2.90% ROA-48.10% Target Price44.00 Perf Year-85.48%
Cash/sh3.65 P/C0.38 EPS next 5Y38.00% ROE-144.60% 52W Range1.46 - 11.66 Perf YTD-69.18%
Dividend- P/FCF- EPS past 5Y-7.20% ROI- 52W High-88.08% Beta1.28
Dividend %- Quick Ratio1.90 Sales past 5Y2.40% Gross Margin0.30% 52W Low-4.79% ATR0.31
Employees300 Current Ratio2.10 Sales Q/Q4.60% Oper. Margin-48.60% RSI (14)18.71 Volatility10.92% 14.58%
OptionableYes Debt/Eq2.03 EPS Q/Q21.10% Profit Margin-52.50% Rel Volume2.91 Prev Close1.52
ShortableYes LT Debt/Eq1.27 EarningsMay 16 AMC Payout- Avg Volume53.12K Price1.39
Recom2.00 SMA20-46.60% SMA50-61.78% SMA200-71.60% Volume154,423 Change-8.55%
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Nov-06-13Reiterated Summer Street Research Buy
Sep-05-13Reiterated Summer Street Research Buy $20 → $25
Aug-02-13Reiterated Summer Street Research Buy $20
Apr-11-12Initiated Summer Street Research Buy $20
Mar-12-12Initiated Stifel Nicolaus Buy $15
Jan-03-12Initiated Canaccord Genuity Buy $14
Dec-10-09Initiated JMP Securities Mkt Outperform $11
Oct-12-09Initiated Wedbush Morgan Outperform $12
May-23-22 08:00AM  
May-16-22 04:02PM  
May-12-22 10:53AM  
May-11-22 08:00AM  
Apr-29-22 08:25AM  
Apr-25-22 08:00AM  
Apr-20-22 08:00AM  
Apr-11-22 09:00AM  
Mar-15-22 09:00AM  
Mar-09-22 09:00AM  
Mar-01-22 08:55AM  
Feb-15-22 08:30AM  
Feb-14-22 04:05PM  
Jan-20-22 09:15AM  
Jan-14-22 03:05PM  
Jan-13-22 11:42AM  
Jan-07-22 12:00PM  
Dec-14-21 09:00AM  
Nov-17-21 02:39PM  
Nov-16-21 04:01PM  
Nov-15-21 05:15PM  
Nov-12-21 04:05PM  
Nov-11-21 08:30AM  
Nov-08-21 07:00AM  
Nov-04-21 04:01PM  
Nov-01-21 03:01PM  
Sep-09-21 09:52AM  
Aug-19-21 04:00PM  
Aug-16-21 06:35PM  
Aug-09-21 03:00PM  
Jul-29-21 07:00AM  
Jun-28-21 07:00AM  
Jun-18-21 12:52PM  
Jun-14-21 08:07AM  
Jun-11-21 12:20PM  
Jun-08-21 07:00AM  
Jun-07-21 09:29AM  
Jun-03-21 07:00AM  
May-17-21 04:05PM  
May-03-21 07:00AM  
Apr-27-21 07:00AM  
Apr-26-21 06:29AM  
Apr-22-21 04:05PM  
Apr-06-21 10:08AM  
Mar-31-21 05:45PM  
Mar-26-21 12:34PM  
Mar-24-21 12:30PM  
Mar-18-21 07:00AM  
Mar-17-21 08:34AM  
Mar-04-21 12:30PM  
Feb-09-21 01:45PM  
Feb-01-21 08:08AM  
Jan-14-21 08:47AM  
Jan-13-21 07:00AM  
Jan-05-21 07:00AM  
Dec-16-20 07:00AM  
Dec-02-20 04:07AM  
Nov-29-20 04:57PM  
Nov-09-20 05:02PM  
Nov-02-20 12:30PM  
Oct-27-20 08:00AM  
Oct-13-20 08:00AM  
Sep-24-20 06:09PM  
Sep-23-20 08:45AM  
Sep-22-20 09:52AM  
Sep-21-20 03:30PM  
Sep-15-20 07:59AM  
Sep-11-20 10:09AM  
Sep-10-20 09:52AM  
Sep-09-20 04:15PM  
Sep-08-20 08:00AM  
Aug-27-20 02:49PM  
Aug-10-20 06:35PM  
Aug-03-20 04:05PM  
Jun-17-20 08:43AM  
Jun-10-20 04:30PM  
May-27-20 12:43PM  
May-26-20 07:00AM  
Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.